Assembly bio announces upcoming investor events

South san francisco, calif., feb. 19, 2021 (globe newswire) -- assembly biosciences, inc. (nasdaq: asmb), a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis b virus (hbv), today announced two upcoming investor events:

ASMB Ratings Summary

ASMB Quant Ranking